Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-03-11 @ 7:09 PM
Study NCT ID:
NCT01646593
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2014-12-15
First Post:
2012-07-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
16339
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Therapeutic Area Head
Old Organization:
Bayer Healthcare AG